TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $452,000 | -39.9% | 6,002 | -76.5% | 0.00% | 0.0% |
| Q1 2022 | $752,000 | +151.5% | 25,553 | +308.0% | 0.00% | – |
| Q4 2021 | $299,000 | -30.9% | 6,263 | -4.0% | 0.00% | – |
| Q3 2021 | $433,000 | -33.9% | 6,523 | -22.3% | 0.00% | -100.0% |
| Q2 2021 | $655,000 | -98.5% | 8,393 | -98.2% | 0.00% | -97.8% |
| Q1 2021 | $43,969,000 | +417.8% | 464,833 | +567.1% | 0.04% | +400.0% |
| Q4 2020 | $8,492,000 | +180.0% | 69,684 | +100.7% | 0.01% | +125.0% |
| Q3 2020 | $3,033,000 | +30.5% | 34,715 | -3.5% | 0.00% | +33.3% |
| Q2 2020 | $2,324,000 | -75.7% | 35,980 | -83.2% | 0.00% | -62.5% |
| Q1 2020 | $9,566,000 | +39.8% | 214,198 | +95.0% | 0.01% | 0.0% |
| Q4 2019 | $6,843,000 | +8453.8% | 109,863 | +5045.8% | 0.01% | – |
| Q3 2019 | $80,000 | – | 2,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |